Century Therapeutics's market cap is currently $62.08M. The company's EPS TTM is $-1.857; its P/E ratio is ―; Century Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.23M	$ 5.20M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -10.81M	$ -4.87M	$ -4.58M	$ -1.75M	$ -249.00K
Operating Income	$ -146.55M	$ -133.83M	$ -94.88M	$ -53.90M	$ -245.98M
EBITDA	$ -121.21M	$ -119.34M	$ -89.92M	$ -51.44M	$ -19.78M
Net Income	$ -136.67M	$ -130.93M	$ -95.82M	$ -54.66M	$ -245.98M
Balance Sheet
Cash & Short-Term Investments	$ 172.74M	$ 315.50M	$ 222.88M	$ 75.75M	$ 81.54M
Total Assets	$ 360.69M	$ 486.54M	$ 437.38M	$ 106.78M	$ 90.90M
Total Debt	$ 48.17M	$ 49.41M	$ 23.46M	$ 21.55M	$ 0.00
Net Debt	$ 847.00K	$ -34.85M	$ -32.98M	$ -5.66M	$ -44.06M
Total Liabilities	$ 175.94M	$ 183.81M	$ 41.14M	$ 213.19M	$ 182.75M
Stockholders' Equity	$ 184.75M	$ 302.74M	$ 396.24M	$ -106.41M	$ -91.86M
Cash Flow
Free Cash Flow	$ -102.08M	$ -16.55M	$ -133.97M	$ -51.09M	$ -18.63M
Operating Cash Flow	$ -88.35M	$ 14.05M	$ -89.00M	$ -41.27M	$ -16.17M
Investing Cash Flow	$ 61.13M	$ -13.13M	$ -298.34M	$ -22.76M	$ -19.83M
Financing Cash Flow	$ -9.72M	$ 27.16M	$ 417.77M	$ 47.69M	$ 74.84M

Currency in USD

Century Therapeutics Earnings and Revenue History

Income Statement >

Century Therapeutics Debt to Assets

Balance Sheet >

Century Therapeutics Cash Flow

Cash Flow >

Century Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing